JL1 Antigen Expression on Bone Marrow Lymphoma Cells from Patients With Non-Hodgkin Lymphoma

BACKGROUND: JL1, a CD43 epitope and mucin family cell surface glycoprotein, is expressed on leukemic cells. An anti-JL1 antibody combined with a toxic substance can have targeted therapeutic effects against JL1-positive leukemia; however, JL1 expression on bone marrow (BM) lymphoma cells has not bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Min-Sun, Park, Chan-Jeoung, Cho, Young-Uk, Jang, Seongsoo, Seo, Eul-Ju, Park, Chan-Sik, Huh, Jooryung, Im, Ho Joon, Seo, Jong Jin, Yoon, Dok Hyun, Suh, Cheolwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713657/
https://www.ncbi.nlm.nih.gov/pubmed/31432632
http://dx.doi.org/10.3343/alm.2020.40.1.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713657/
https://www.ncbi.nlm.nih.gov/pubmed/31432632
http://dx.doi.org/10.3343/alm.2020.40.1.1

Ejemplares similares